Speech Recognition Systems 의 안전성 경고

Safety alert

554

2002-03-08

Brazil

ANVISA

http://www.anvisa.gov.br/sistec/alerta/consultaralerta.asp

Ecri has found that in some cases, speech recognition software can replace one drug name with another (eg clonidine by quinidine). if a physician dictates a report using a failed speech recognition system, if there is a substitution, a patient may receive the wrong medication, or the patient's medical record may appear to be the wrong medication, creating a risk to patient safety.

ECRI recommends the following to prevent substitution of the drug name when using speech recognition system; these recommendations also apply to the use of traditional transcription methods: (1) To alert clinicians to the potential for misinterpretation of drug names when using speech recognition systems. When appropriate, provide in-service training for staff on how and why this problem occurs, and how this can be avoided, such as speaking clearly and slowly or spelling words when dictating drug names. (2) Remind clinicians that they should always check drug names before signing the final report. (3) If you are using a speech recognition system, to report dictation, make sure this instrument provides a pharmaceutical vocabulary or dictionary. If not, most systems will provide specific vocabularies to be imported or downloaded into it. In some cases, the user may need to train the system to recognize this imported vocabulary. ANVISA has provided the Occurrence Notification Forms on the Internet www.anvisa.gov.br/tecnovigilancia to notify you if you encounter any problems with the products in your inventory. For further information, please contact ANVISA's Tecnovigilância Unit, by e-mail tecnovigilancia@anvisa.gov.br or by telephone (61) 448-1485.